Table 2.
Sample characteristics according to the types of cancer
Type of cancer | |||||||
---|---|---|---|---|---|---|---|
Characteristics | Total sample | UGITa | LGITb | RSc | Lung | Breast | Othersd |
Type of cancer - n (%) | 277 (100) | 43 (15.5) | 58 (20.9) | 52 (18.8) | 32 (11.6) | 30 (10.8) | 62 (22.4) |
Age - Mean (SD) | 54.7 (14.9) | 57.6(13.3) | 57.6 (12.9) | 52.9 (15.3) | 57.7 (13.8) | 56.6 (15.5) | 48.8 (16.2) |
≥60 - n (%) | 109 (39.4) | 20 (18.3) | 29 (26.6) | 19 (17.4) | 13 (11.9) | 12 (11.0) | 16 (14.7) |
Gender - n (%) | |||||||
Male | 122 (44.0) | 23 (18.9) | 20 (16.4) | 15 (12.3) | 21 (17.2) | 0 (0.0) | 43 (35.2) |
Female | 155 (56.0) | 20 (12.9) | 38 (24.5) | 37 (23.9) | 11 (7.1) | 30 (19.4) | 19 (12.3) |
Metastasis - n (%) | |||||||
Absent | 138 (49.8) | 15 (10.9) | 29 (21.0) | 26 (18.8) | 11 (8.0) | 19 (13.8) | 38 (27.5) |
Present | 139 (50.2) | 28 (20.1) | 29 (20.9) | 26 (18.7) | 21 (15.1) | 11 (7.9) | 24 (17.3) |
Performance status - n (%) | |||||||
<2 | 149 (53.8) | 20 (13.4) | 36 (24.2) | 23 (15.4) | 14 (9.4) | 17 (11.4) | 39 (26.2) |
≥2 | 128 (46.2) | 23 (18.0) | 22 (17.2) | 29 (22.7) | 18 (14.1) | 13 (10.2) | 23 (18.0) |
Symptoms of impact - n (%) | |||||||
Yes | 186 (67.1) | 31 (16.7) | 35 (18.8) | 39 (21.0) | 26 (14.0) | 17 (9.1) | 38 (20.4) |
No | 91 (32.9) | 12 (13.2) | 23 (25.3) | 13 (14.3) | 6 (6.6) | 13 (14.3) | 24 (26.4) |
%WL ≥5 em 6 meses - n (%) | |||||||
Yes | 101 (80.2) | 20 (19.8) | 21 (20.8) | 15 (14.9) | 15 (14.9) | 5 (5.0) | 25 (24.8) |
No | 25 (19.8) | 2 (8.0) | 5 (20.0) | 7 (28.0) | 1 (4.0) | 4 (16.0) | 6 (24.0) |
Overweight (pBMI) - n (%) | |||||||
Yes | 76 (60.3) | 14 (18.4) | 12 (15.8) | 15 (19.7) | 12 (15.8) | 4 (5.3) | 19 (25.0) |
No | 50 (39.7) | 8 (16.0) | 14 (28.0) | 7 (14.0) | 4 (8.0) | 5 (10.0) | 12 (24.0) |
PG-SGA - n (%) | |||||||
Well nourished | 80 (28.9) | 7 (8.8) | 19 (23.8) | 13 (16.3) | 5 (6.3) | 13 (16.3) | 23 (28.8) |
Moderate malnutrition | 98 (35.4) | 8 (8.2) | 21 (21.4) | 21 (21.4) | 17 (17.3) | 12 (12.2) | 19 (19.4) |
Severe malnutrition | 99 (35.7) | 28 (28.3) | 18 (18.2) | 18 (18.2) | 10 (10.1) | 5 (5.1) | 20 (20.2) |
SD standard deviation, PS performance status, %WL weight loss percentage, PG-SGA patient-generated subjective global assessment; aUpper gastrointestinal tract: esophagus, stomach, pancreas, liver, gallbladder, biliary ducts; bLower gastrointestinal tract: colon, rectum and anal canal; cReproductive system: ovarian, cervical, testicular and prostate; dHead and neck, hematological, unknown primary site, sarcoma, melanoma